{"product_id":"bpc-157","title":"BPC-157","description":"\u003ch1\u003eBPC-157 Peptide Overview\u003c\/h1\u003e\n\u003cp class=\"\"\u003eBPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a naturally occurring protein fragment found in human gastric juice. It consists of 15 amino acids and has demonstrated remarkable stability in biological environments. BPC-157 has been extensively studied in preclinical research for its protective and regenerative effects across multiple tissue systems, particularly in models of soft tissue injury, gastrointestinal damage, and vascular dysfunction.\u003c\/p\u003e\n\u003ch2\u003eTissue Repair and Regenerative Effects of BPC-157\u003c\/h2\u003e\n\u003ch3\u003eAccelerates Soft Tissue Healing\u003c\/h3\u003e\n\u003cp class=\"\"\u003eBPC-157 has been shown to significantly enhance the healing of tendons, ligaments, muscles, and skin in animal models. It promotes fibroblast activity, supports collagen organization, and improves structural integrity at injury sites. These effects have been observed even in compromised healing conditions, including corticosteroid exposure and poor circulation.\u003c\/p\u003e\n\u003cp class=\"\"\u003e\u003cstrong\u003eSupported by:\u003c\/strong\u003e\u003cbr\u003eStaresinic et al., \u003cem\u003eJournal of Orthopaedic Research\u003c\/em\u003e; Seiwerth et al., \u003cem\u003eCurrent Pharmaceutical Design\u003c\/em\u003e\u003c\/p\u003e\n\u003ch3\u003eEnhances Angiogenesis and Blood Vessel Integrity\u003c\/h3\u003e\n\u003cp class=\"\"\u003eProper blood flow is essential for tissue repair. BPC-157 has been shown to promote angiogenesis and stabilize existing blood vessels, improving perfusion to injured tissue. Research demonstrates that it can rapidly restore vascular function following trauma, ischemia, or chemical injury, supporting faster and more complete recovery.\u003c\/p\u003e\n\u003cp class=\"\"\u003e\u003cstrong\u003eSupported by:\u003c\/strong\u003e\u003cbr\u003eSikiric et al., \u003cem\u003eJournal of Physiology and Pharmacology\u003c\/em\u003e; Cesarec et al., \u003cem\u003eMicrovascular Research\u003c\/em\u003e\u003c\/p\u003e\n\u003ch2\u003eGastrointestinal Protective Properties\u003c\/h2\u003e\n\u003ch3\u003eProtects and Repairs the Gastrointestinal Tract\u003c\/h3\u003e\n\u003cp class=\"\"\u003eBPC-157 was originally studied for its potent protective effects on the gastrointestinal system. Research shows it can prevent and heal damage to the stomach and intestines caused by NSAIDs, alcohol, stress, and inflammatory conditions. It supports mucosal integrity, enhances epithelial repair, and reduces inflammation throughout the GI tract.\u003c\/p\u003e\n\u003cp class=\"\"\u003e\u003cstrong\u003eSupported by:\u003c\/strong\u003e\u003cbr\u003eSikiric et al., \u003cem\u003eAlimentary Pharmacology \u0026amp; Therapeutics\u003c\/em\u003e; Seiwerth et al., \u003cem\u003eJournal of Physiology-Paris\u003c\/em\u003e\u003c\/p\u003e\n\u003ch3\u003eSupports Gut-Brain Axis Stability\u003c\/h3\u003e\n\u003cp class=\"\"\u003ePreclinical studies suggest BPC-157 may influence the gut-brain axis by stabilizing neurotransmitter systems and reducing inflammation. These effects may contribute to its observed protective actions in models of stress, anxiety-like behavior, and central nervous system injury.\u003c\/p\u003e\n\u003cp class=\"\"\u003e\u003cstrong\u003eSupported by:\u003c\/strong\u003e\u003cbr\u003eSikiric et al., \u003cem\u003eNeuropharmacology\u003c\/em\u003e; Vlainic et al., \u003cem\u003eBehavioural Brain Research\u003c\/em\u003e\u003c\/p\u003e\n\u003ch2\u003eAnti-Inflammatory and Cytoprotective Effects\u003c\/h2\u003e\n\u003cp class=\"\"\u003eBPC-157 exhibits strong anti-inflammatory activity by modulating nitric oxide pathways, reducing oxidative stress, and stabilizing cellular membranes. Unlike traditional anti-inflammatory agents, BPC-157 does not inhibit cyclooxygenase pathways, allowing it to reduce inflammation without impairing normal healing processes.\u003c\/p\u003e\n\u003cp class=\"\"\u003e\u003cstrong\u003eSupported by:\u003c\/strong\u003e\u003cbr\u003eSikiric et al., \u003cem\u003eInflammopharmacology\u003c\/em\u003e; Seiwerth et al., \u003cem\u003eCurrent Pharmaceutical Design\u003c\/em\u003e\u003c\/p\u003e\n\u003ch2\u003eNeuroprotective and Systemic Protective Potential\u003c\/h2\u003e\n\u003cp class=\"\"\u003eBPC-157 has demonstrated neuroprotective effects in experimental models of brain and spinal cord injury. Studies show reduced neuronal damage, improved functional recovery, and stabilization of dopaminergic and serotonergic systems. Additional research suggests systemic protective effects across cardiovascular, hepatic, and renal models of injury.\u003c\/p\u003e\n\u003cp class=\"\"\u003e\u003cstrong\u003eSupported by:\u003c\/strong\u003e\u003cbr\u003eVlainic et al., \u003cem\u003eNeuropharmacology\u003c\/em\u003e; Sikiric et al., \u003cem\u003eMedical Hypotheses\u003c\/em\u003e\u003c\/p\u003e\n\u003ch2\u003eBPC-157 Peptide Specifications\u003c\/h2\u003e\n\u003cul data-rte-list=\"default\"\u003e\n\u003cli\u003e\n\u003cp class=\"\"\u003e\u003cstrong\u003eCAS Number:\u003c\/strong\u003e 137525-51-0\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"\"\u003e\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e C₆₂H₉₈N₁₆O₂₂\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"\"\u003e\u003cstrong\u003eMolecular Weight:\u003c\/strong\u003e 1419.5 g\/mol\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"\"\u003e\u003cstrong\u003ePeptide Class:\u003c\/strong\u003e Pentadecapeptide (15 amino acids)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"\"\u003e\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilized powder in sterile glass vial\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"\"\u003e\u003cstrong\u003ePurity:\u003c\/strong\u003e ≥98%\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"\"\u003e\u003cstrong\u003eQuantity:\u003c\/strong\u003e Commonly supplied as 5 mg or 10 mg per vial\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"\"\u003e\u003cstrong\u003eColor:\u003c\/strong\u003e White to off-white powder\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"\"\u003e\u003cstrong\u003eStorage:\u003c\/strong\u003e Refrigerate after reconstitution\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eImportant Notice\u003c\/h2\u003e\n\u003cp class=\"\"\u003eThis compound is intended \u003cstrong\u003estrictly for in vitro laboratory research\u003c\/strong\u003e conducted by qualified professionals. BPC-157 is \u003cstrong\u003enot approved by the U.S. Food and Drug Administration (FDA)\u003c\/strong\u003e for human or veterinary use and must not be marketed, labeled, or represented as a drug, dietary supplement, cosmetic, or food product.\u003c\/p\u003e\n\u003ch1\u003eReferences\u003c\/h1\u003e\n\u003col data-rte-list=\"default\" id=\"yui_3_17_2_1_1772482244538_501\"\u003e\n\u003cli\u003e\n\u003cp class=\"\"\u003eSikiric P et al. \u003cstrong\u003eStable gastric pentadecapeptide BPC-157: novel therapy in gastrointestinal and extra-intestinal disorders.\u003c\/strong\u003e \u003cem\u003eAlimentary Pharmacology \u0026amp; Therapeutics.\u003c\/em\u003e\u003cbr\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/11207720\/\"\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/11207720\/\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"\"\u003eSeiwerth S et al. \u003cstrong\u003eBPC-157 and wound healing: experimental and clinical evidence.\u003c\/strong\u003e \u003cem\u003eCurrent Pharmaceutical Design.\u003c\/em\u003e\u003cbr\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20491627\/\"\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/20491627\/\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"\"\u003eStaresinic M et al. \u003cstrong\u003eBPC-157 improves tendon healing and ligament regeneration.\u003c\/strong\u003e \u003cem\u003eJournal of Orthopaedic Research.\u003c\/em\u003e\u003cbr\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/18566906\/\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"\"\u003eCesarec V et al. \u003cstrong\u003eBPC-157 improves angiogenesis and vascular recovery.\u003c\/strong\u003e \u003cem\u003eMicrovascular Research.\u003c\/em\u003e\u003cbr\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24486625\/\"\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/24486625\/\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"\"\u003eVlainic J et al. \u003cstrong\u003eBPC-157 neuroprotective effects in central nervous system injury models.\u003c\/strong\u003e \u003cem\u003eNeuropharmacology.\u003c\/em\u003e\u003cbr\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23911976\/\"\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/23911976\/\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli id=\"yui_3_17_2_1_1772482244538_500\"\u003e\n\u003cp class=\"\" id=\"yui_3_17_2_1_1772482244538_499\"\u003eSikiric P et al. \u003cstrong\u003eNitric oxide system modulation by BPC-157.\u003c\/strong\u003e \u003cem\u003eJournal of Physiology and Pharmacology.\u003c\/em\u003e\u003cbr\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16227745\/\"\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/16227745\/\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"\"\u003eSeiwerth S et al. \u003cstrong\u003eCytoprotection and anti-inflammatory effects of BPC-157.\u003c\/strong\u003e \u003cem\u003eInflammopharmacology.\u003c\/em\u003e\u003cbr\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/20112070\/\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"\"\u003eVlainic J et al. \u003cstrong\u003eBPC-157 and the gut-brain axis.\u003c\/strong\u003e \u003cem\u003eBehavioural Brain Research.\u003c\/em\u003e\u003cbr\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27157665\/\"\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/27157665\/\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch2\u003e\u003cstrong\u003eComplete Disclaimer\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp class=\"\" id=\"yui_3_17_2_1_1772482244538_476\"\u003eThis product is sold exclusively for laboratory research purposes under Section 351 of the Public Health Service Act. It is not intended for human or veterinary use, nor for diagnostic, therapeutic, or cosmetic applications. Purchaser certifies they are properly licensed and equipped to handle research compounds in compliance with all local, state, and federal regulations. Eaglepeptidesusa.com assumes no liability for misuse or unauthorized handling. By purchasing, you affirm this material will not be introduced into interstate commerce or used in food\/drug products.\u003c\/p\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":53220072587628,"sku":null,"price":55.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0978\/1539\/6716\/files\/EAGLE_PEPTIDES_BPC-157.png?v=1772470791","url":"https:\/\/eaglepeptidesusa.com\/products\/bpc-157","provider":"My Store","version":"1.0","type":"link"}